Transforming growth factor-α production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene

• Published in: Cancer research (Chicago, Ill.) Vol. 53; no. 7; pp. 1630 - 1636
• Main Authors: SEEMA UNTAWALE, ZORBAS, M. A, BOMAN, B. M, HODGSON, C. P, COFFEY, R. J, GALLICK, G. E, NORTH, S. M, WILDRICK, D. M, OLIVE, M, BLICK, M, YEOMAN, L. C
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 01.04.1993
• Subjects: Biological and medical sciences; Blotting, Northern; Blotting, Southern; Colorectal Neoplasms - metabolism; DNA, Neoplasm - analysis; Gastroenterology. Liver. Pancreas. Abdomen; Gene Amplification - genetics; Humans; Medical sciences; Phosphorylation; Receptor, Epidermal Growth Factor - analysis; Receptor, Epidermal Growth Factor - genetics; Receptor, Epidermal Growth Factor - metabolism; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Transforming Growth Factor alpha - biosynthesis; Tumor Cells, Cultured; Tumors; Up-Regulation; Human; Cell proliferation; Carcinoma; Transforming growth factor; Cytokine; Malignant tumor; Gene expression; In vitro; Autocrine secretion; Gene amplification; Epidermal growth factor; Messenger RNA; Established cell line; Rectum; Digestive diseases; Intestinal disease; Colon; Tumor cell; Biological receptor
• ISSN: 0008-5472; 1538-7445

The DiFi colorectal carcinoma cell line, derived from a patient with familial adenomatous polyposis, was examined for gene expression and production of the autocrine growth factor transforming growth factor alpha (TGF-alpha) and for epidermal growth factor receptor (EGFR) gene expression and gene copy number. DiFi cells expressed TGF-alpha transcripts as identified on Northern (RNA) blots. Addition of TGF-alpha (10 ng/ml) or EGF (10 ng/ml) to DiFi cell cultures (lacking EGF or serum) up-regulated DiFi cell basal TGF-alpha mRNA levels, suggesting that autoinduction of TGF-alpha occurs in these cells. DiFi cell cultures in log phase growth secreted measurable amounts of TGF-alpha (347 pg/10(6) cells/24 h) into their culture medium, as determined by radioimmunoassay. DiFi cells showed strong overexpression of the EGFR gene on Northern blots relative to three other colon cancer cell lines examined. Immunoperoxidase staining showed enhanced EGFR expression in a cell subpopulation among the original (uncultured) ascitic fluid cells from which the DiFi cell line was established. This cell subpopulation was observed to expand dramatically between passages 1 and 25. Immune complex kinase assay of DiFi cells showed that EGFR were functional as determined by their ability to autophosphorylate. The EGFR gene in these cells was not found to be rearranged or genetically altered using Southern blot analysis. Dot blot analysis of DiFi cell DNA revealed EGFR gene amplification in the range of 60-80 copies/cell, which is approximately twice the copy number seen in A-431 epidermoid carcinoma cells. To our knowledge DiFi cells represent the first example of EGFR gene amplification in a colorectal adenocarcinoma. Because DiFi colorectal cancer cells uniquely show production and auto-induction of TGF-alpha in addition to amplification and overexpression of the EGFR gene, these cells represent a valuable tool for studying the role(s) of the EGFR in the regulation of tumor cell growth.